Sector Gamma AS’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.42M | Sell |
53,247
-123,167
| -70% | -$17.2M | 1.75% | 19 |
|
|
2025
Q4 | $21.7M | Buy |
176,414
+29,175
| +20% | +$3.55M | 4.94% | 5 |
|
|
2025
Q3 | $16.3M | Buy |
147,239
+20,239
| +16% | +$2.3M | 4.05% | 9 |
|
|
2025
Q2 | $14.1M | Sell |
127,000
-13,000
| -9% | -$1.38M | 4.6% | 6 |
|
|
2025
Q1 | $15.7M | Sell |
140,000
-57,500
| -29% | -$5.93M | 5.02% | 7 |
|
|
2024
Q4 | $18.2M | Sell |
197,500
-91,663
| -32% | -$8.25M | 6.27% | 4 |
|
|
2024
Q3 | $24.2M | Sell |
289,163
-131,000
| -31% | -$10M | 7.36% | 3 |
|
|
2024
Q2 | $28.8M | Buy |
420,163
+154,544
| +58% | +$10.3M | 10.77% | 1 |
|
|
2024
Q1 | $19.5M | Sell |
265,619
-116,743
| -31% | -$8.98M | 5.48% | 6 |
|
|
2023
Q4 | $31M | Sell |
382,362
-240,761
| -39% | -$18.7M | 7.52% | 3 |
|
|
2023
Q3 | $46.7M | Buy |
623,123
+21,756
| +4% | +$1.67M | 11.93% | 1 |
|
|
2023
Q2 | $46.3M | Buy |
601,367
+58,594
| +11% | +$4.67M | 10.37% | 1 |
|
|
2023
Q1 | $45M | Sell |
542,773
-53,263
| -9% | -$4.41M | 10.92% | 1 |
|
|
2022
Q4 | $51.2M | Sell |
596,036
-287,070
| -33% | -$22.7M | 11.7% | 1 |
|
|
2022
Q3 | $54.5M | Buy |
883,106
+39,679
| +5% | +$2.5M | 14.04% | 1 |
|
|
2022
Q2 | $52.1M | Buy |
843,427
+161,889
| +24% | +$10M | 11.66% | 1 |
|
|
2022
Q1 | $40.5M | Buy |
681,538
+384,483
| +129% | +$24.6M | 8.8% | 2 |
|
|
2021
Q4 | $21.6M | Sell |
297,055
-74,030
| -20% | -$5.1M | 5.07% | 5 |
|
|
2021
Q3 | $25.9M | Sell |
371,085
-206,283
| -36% | -$14.5M | 5.17% | 5 |
|
|
2021
Q2 | $39.8M | Sell |
577,368
-101,265
| -15% | -$6.76M | 7.04% | 2 |
|
|
2021
Q1 | $43.9M | Sell |
678,633
-159,507
| -19% | -$10.3M | 8.03% | 2 |
|
|
2020
Q4 | $48.8M | Buy |
838,140
+361,046
| +76% | +$21.8M | 9.29% | 1 |
|
|
2020
Q3 | $30.1M | Buy |
477,094
+43,310
| +10% | +$3M | 6.86% | 4 |
|
|
2020
Q2 | $33.4M | Buy |
433,784
+234,365
| +118% | +$18M | 6.89% | 2 |
|
|
2020
Q1 | $14.9M | Sell |
199,419
-216,186
| -52% | -$14.9M | 3.18% | 15 |
|
|
2019
Q4 | $27M | Sell |
415,605
-59,451
| -13% | -$3.87M | 4.33% | 8 |
|
|
2019
Q3 | $30.1M | Buy |
475,056
+30,000
| +7% | +$1.96M | 5.09% | 5 |
|
|
2019
Q2 | $30.1M | Sell |
445,056
-133,681
| -23% | -$8.79M | 4.83% | 5 |
|
|
2019
Q1 | $37.6M | Buy |
578,737
+144,380
| +33% | +$9.6M | 6.03% | 4 |
|
|
2018
Q4 | $27.2M | Buy |
434,357
+111,170
| +34% | +$7.77M | 4.57% | 7 |
|
|
2018
Q3 | $25M | Buy |
323,187
+31,587
| +11% | +$2.39M | 3.91% | 10 |
|
|
2018
Q2 | $20.7M | Buy |
291,600
+188,100
| +182% | +$13.3M | 3.43% | 12 |
|
|
2018
Q1 | $7.8M | Sell |
103,500
-254,390
| -71% | -$20.2M | 1.41% | 22 |
|
|
2017
Q4 | $25.6M | Buy |
357,890
+22,200
| +7% | +$1.69M | 4.31% | 8 |
|
|
2017
Q3 | $27.2M | Sell |
335,690
-212,700
| -39% | -$16.3M | 4.15% | 9 |
|
|
2017
Q2 | $38.8M | Buy |
548,390
+99,900
| +22% | +$6.65M | 5.64% | 7 |
|
|
2017
Q1 | $30.5M | Buy |
448,490
+89,200
| +25% | +$6.27M | 4.84% | 10 |
|
|
2016
Q4 | $25.7M | Sell |
359,290
-5,700
| -2% | -$424K | 4.84% | 8 |
|
|
2016
Q3 | $27M | Buy |
+364,990
| New | +$29.6M | 4.73% | 8 |
|
Other funds holding GILD
VCM
VPM
Sector Gamma AS's GILD Position: Q1 2026 in Review
Sector Gamma AS reduced its Gilead Sciences (GILD) stake by 70% in Q1 2026, selling an estimated $17.2M and leaving 53,247 shares worth $7.42M. The position accounts for 1.75% of the portfolio, ranked #19.
Sector Gamma AS first reported a position in GILD in Q3 2016 and has held it in 39 quarters since. The position peaked at $54.5M in Q3 2022. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Sector Gamma AS held 53,247 shares of Gilead Sciences worth $7.42M as of Q1 2026.
- Sector Gamma AS sold 123,167 Gilead Sciences shares in Q1 2026, an estimated $17.2M.
- Gilead Sciences made up 1.75% of Sector Gamma AS's portfolio in Q1 2026, its #19 holding.
- Sector Gamma AS first reported a position in Gilead Sciences in Q3 2016 and has held it in 39 quarters since.
- Sector Gamma AS's Gilead Sciences position peaked at $54.5M in Q3 2022.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Sector Gamma AS's 13F filing for Q1 2026, filed 7 May 2026.